{"id":"NCT04115293","sponsor":"Ra Pharmaceuticals, Inc.","briefTitle":"Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis","officialTitle":"A Phase 3, Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-09-17","primaryCompletion":"2021-12-30","completion":"2021-12-30","firstPosted":"2019-10-04","resultsPosted":"2023-01-17","lastUpdate":"2025-07-16"},"enrollment":174,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Myasthenia Gravis, Generalized"],"interventions":[{"type":"DRUG","name":"zilucoplan (RA101495)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"0.3 mg/kg zilucoplan (RA101495)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The RAISE study is a multicenter, randomized, double-blind, placebo controlled study to confirm the efficacy, safety, and tolerability of zilucoplan in subjects with generalized Myasthenia Gravis. Subjects will be randomized in a 1:1 ratio to receive daily SC doses of 0.3 mg/kg zilucoplan or placebo for 12 weeks.","primaryOutcome":{"measure":"Change From Baseline (CFB) to Week 12 in Myasthenia Gravis-Activities of Daily Living (MG-ADL) Total Score","timeFrame":"From Baseline to End of Treatment (Week 12)","effectByArm":[{"arm":"Placebo","deltaMin":-2.3,"sd":null},{"arm":"Zilucoplan 0.3 mg/kg","deltaMin":-4.39,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":3},"locations":{"siteCount":77,"countries":["United States","Canada","France","Germany","Italy","Japan","Norway","Poland","Spain","United Kingdom"]},"refs":{"pmids":["37059508","38400914","39314260","40504283"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":88},"commonTop":["Headache","Injection site bruising","Myasthenia gravis","Diarrhoea","Injection site pain"]}}